Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era

Journal of Heart and Lung Transplantation

Volumn 22, Issue 10, 2003, Pages 1098-1106

  Shiba, Nobuyuki ^a   Chan, Michael C Y ^a   Valantine, Hannah A ^a   Gao, Shao Zhou ^a   Robbins, Robert C ^b   Hunt, Sharon A ^a,c  

^a Division of Cardiovascular Medicine   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DONOR; ETHNIC GROUP; FEMALE; GENDER; GRAFT REJECTION; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIVARIATE ANALYSIS; POPULATION; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; RISK; SURVIVAL TIME;

EID: 0141656293     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)01192-0     Document Type: Article

References (35)

1. Hunt S.A. Current status of cardiac transplantation. JAMA. 280:1998;1692-1698.
2. Bourge R.C., Naftel D.C., Costanzo-Nordin M.R., et al. Pretransplantation risk factors for death after heart transplantation a multiinstitutional study. The Transplant Cardiologists Research Database Group . J Heart Lung Transplant. 12:1993;549-562.
3. Hosenpud J.D., Bennett L.E., Keck B.M., Fiol B., Boucek M.M., Novick R.J. The registry of the International Society for Heart and Lung Transplantation sixteenth official report - 1999 . J Heart Lung Transplant. 18:1999;611-626.
4. McCarthy P.M., Smith J.A., Siegel L.C., et al. Cardiac transplant admission, anesthesia, and operative procedures. Smith J.A., McCarthy P.M., Sarris G.E., Stinson E.B., Reitz B.A. The Stanford manual of cardiopulmonary transplantation. 1996;31-61 Futura, Armonk, NY.
5. Sarris G.E., Moore K.A., Schroeder J.S., et al. Cardiac transplantation the Stanford experience in the cyclosporine era . J Thorac Cardiovasc Surg. 108:1994;240-251.
6. McCarthy J.F., McCarthy P.M., Massad M.G., et al. Risk factors for death after heart transplantation does a single-center experience correlate with multicenter registries? Ann Thorac Surg. 65:1998;1574-1578.
7. Baron O., Trochu J.N., Treilhaud M., et al. Cardiac transplantation in patients over 60 years of age. Transplant Proc. 31:1999;75-78.
8. Renlund D.G., Gilbert E.M., O'Connell J.B., et al. Age-associated decline in cardiac allograft rejection. Am J Med. 83:1987;391-398.
9. Rickenbacher P.R., Lewis N.P., Valantine H.A., Luikart H., Stinson E.B., Hunt S.A. Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life. Eur Heart J. 18:1997;870-878.
10. Borkon A.M., Muehlebach G.F., Jones P.G., et al. An analysis of the effect of age on survival after heart transplant. J Heart Lung Transplant. 18:1999;668-674.
11. Costanzo M.R., Naftel D.C., Pritzker M.R., et al. Heart transplant coronary artery disease detected by coronary angiography a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database . J Heart Lung Transplant. 17:1998;744-753.
12. Baker A.M., Levine T.B., Goldberg A.D., Levine A.B. Natural history and predictors of obesity after orthotopic heart transplantation. J Heart Lung Transplant. 11:1992;1156-1159.
13. Rickenbacher P.R., Kemna M.S., Pinto F.J., et al. Coronary artery intimal thickening in the transplanted heart an in vivo intracoronary ultrasound study of immunologic and metabolic risk factors . Transplantation. 61:1996;46-53.
14. Grady K.L., White-Williams C., Naftel D., et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality? A multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group. J Heart Lung Transplant. 18:1999;750-763.
15. Prendergast T.W., Furukawa S., Beyer A.J. III, Browne B.J., Eisen H.J., Jeevanandam V. The role of gender in heart transplantation. Ann Thorac Surg. 65:1998;88-94.
16. Lietz K., John R., Kocher A., et al. Increased prevalence of autoimmune phenomena and greater risk for alloreactivity in female heart transplant recipients. Circulation. 104:2001;I177-183.
17. Kirklin J.K., Naftel D.C., McGiffin D.C., et al. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol. 11:1988;917-924.
18. Mills R.M., Naftel D.C., Kirklin J.K., et al. Heart transplant rejection with hemodynamic compromise a multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database . J Heart Lung Transplant. 16:1997;813-821.
19. Chocair P.R., Duley J.A., Sabbaga E., Arap S., Simmonds H.A., Cameron J.S. Fast and slow methylators do racial differences influence risk of allograft rejection? Q J Med. 86:1993;359-363.
20. Thompson J.S., Thacker L.R. Jr, Takemoto S. The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome an analysis from the United Network of Organ Sharing Scientific Registry . Transplantation. 69:2000;2178-2186.
21. Mehra M.R., Uber P.A., Scott R.L., Prasad A.K., Park M.H. Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation. Transplant Proc. 33:2001;1613-1614.
22. Jarcho J., Naftel D.C., Shroyer T.W., et al. Influence of HLA mismatch on rejection after heart transplantation a multi-institutional study. The Cardiac Transplant Research Database Group . J Heart Lung Transplant. 13:1994;583-595.
23. Hosenpud J.D., Edwards E.B., Lin H.M., Daily O.P. Influence of HLA matching on thoracic transplant outcomes an analysis from the UNOS/ISHLT Thoracic Registry . Circulation. 94:1996;170-174.
24. Costanzo-Nordin M.R. Cardiac allograft vasculopathy relationship with acute cellular rejection and histocompatibility . J Heart Lung Transplant. 11:(Suppl):1992;S90-103.
25. Cocanougher B., Ballantyne C.M., Pollack M.S., et al. Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant. Transplant Proc. 25:1993;233-236.
26. John R., Rajasinghe H.A., Itescu S., et al. Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era. J Am Coll Cardiol. 37:2001;189-194.
27. Aziz T., Burgess M., Rahman A.N., Campbell C.S., Yonan N. Cardiac transplantation for cardiomyopathy and ischemic heart disease differences in outcome up to 10 years . J Heart Lung Transplant. 20:2001;525-533.
28. Laske A., Gallino A., Schneider J., et al. Prophylactic cytolytic therapy in heart transplantation monoclonal versus polyclonal antibody therapy . J Heart Lung Transplant. 11:1992;557-563.
29. Adamson R., Obispo E., Dychter S., et al. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients a single-center experience . Transplant Proc. 30:1998;1107-1109.
30. Grattan M.T., Moreno-Cabral C.E., Starnes V.A., Oyer P.E., Stinson E.B., Shumway N.E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 261:1989;3561-3566.
31. Valantine H.A., Gao S.Z., Menon S.G., et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis a post hoc analysis of a randomized, placebo-controlled study . Circulation. 100:1999;6-61.
32. Valantine H.A., Luikart H., Doyle R., et al. Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation a comparative study of combined prophylaxis with CMV hyperimmune globulin plus gancyclovir versus ganciclovir alone . Transplantation. 27:2001;1647-1652.
33. Montoya J.G., Giraldo L.F., Efron B., et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis. 33:2000;629-640.
34. Rodeheffer R.J., Naftel D.C., Stevenson L.W., et al. Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994 a multiinstitutional study. Cardiac Transplant Research Database Group . Circulation. 4:1996;2883-2889.
35. John R., Rajasinghe H.A., Chen J.M., et al. Long-term outcomes after cardiac transplantation an experience based on different eras of immunosuppressive therapy . Ann Thorac Surg. 72:2001;440-449.